Evaluation of the Efficiency and Economic Impact of LC-OCT (Line-field Confocal Optical Coherence Tomography) for the Diagnosis and Management of Basal Cell Carcinomas

NCT06271603 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 704

Last updated 2024-02-22

No results posted yet for this study

Summary

This is a comparative, randomized, prospective, multicenter clinical investigation aimed at evaluating the efficiency and economic impact of LC-OCT (Line-field Confocal Optical Coherence Tomography) for the diagnosis and management of basal cell carcinomas.

Conditions

  • Basal Cell Carcinoma of the Skin

Interventions

DIAGNOSTIC_TEST

diagnosis based on deepLive™ LC-OCT device

Management of BCC with an initial diagnosis based on the deepLive™ device using LC-OCT technology.

DIAGNOSTIC_TEST

diagnosis based on skin biopsy

Control Arm: Standard management with an initial diagnosis based on skin biopsy

Sponsors & Collaborators

  • Damae Medical

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-02-26
Primary Completion
2026-02-28
Completion
2026-02-28

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06271603 on ClinicalTrials.gov